A dose-up of ursodeoxycholic acid decreases transaminases in hepatitis C patients

Figure 1 Changes in serum alanine aminotransferase (ALT) levels, serum aspartate aminotransferase (AST) levels and serum gamma-glutamyl transpeptidase (GGT) levels in patients before and during dose-up to 900 mg/d. Data are expressed as mean ± SD. ^aP < 0.05, ^bP < 0.01; paired t-test compared to week 0 in each parameter.

Figure 2 Changes in serum albumin, platelet count, and total bilirubin levels in chronic hepatitis C patients before and 24 wk after beginning the dose-up to 900 mg/d.